Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors

NCT06094426 · clinicaltrials.gov ↗
EARLY_PHASE1
Phase
TERMINATED
Status
2
Enrollment
INDUSTRY
Sponsor class

Stopped The study was terminated from a business perspective.

Conditions

Interventions

Sponsor

Grit Biotechnology